Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Effect of antireflux treatment on asthma exacerbations in nonatopic children.

Khoshoo V, Haydel R Jr.

J Pediatr Gastroenterol Nutr. 2007 Mar;44(3):331-5.

PMID:
17325553
2.

Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.

Sontag SJ, O'Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A.

Am J Gastroenterol. 2003 May;98(5):987-99.

PMID:
12809818
3.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).

Pediatrics. 2006 May;117(5):e817-20.

PMID:
16651285
4.

A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.

Norman Hansen A, Bergheim R, Fagertun H, Lund H, Moum B.

Int J Clin Pract. 2005 Jun;59(6):665-71. Erratum in: Int J Clin Pract. 2005 Nov;59(11):1371.

PMID:
15924594
5.

[Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].

Maev IV, Viuchnova ES, Balashova NN, Shchekina MI.

Eksp Klin Gastroenterol. 2003;(3):26-31, 116. Russian.

PMID:
14556543
6.

Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.

Tolia V, Gilger MA, Barker PN, Illueca M.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):593-8. doi: 10.1097/MPG.0b013e3181ddcf11.

PMID:
20706150
7.

Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.

Yüksel H, Yilmaz O, Kirmaz C, Aydoğdu S, Kasirga E.

Respir Med. 2006 Mar;100(3):393-8. Epub 2005 Aug 15.

8.

Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.

Rantanen TK, Sihvo EI, Räsänen JV, Salo JA.

Am J Gastroenterol. 2007 Feb;102(2):246-53. Epub 2006 Dec 11.

PMID:
17156140
9.

[Effectiveness of antireflux therapy in asthmatic children with gastroesophageal reflux disease].

Farcău D, Dreghiciu D, Cherecheş-Panţa P, Popa M, Farcău M, Nanulescu M.

Pneumologia. 2004 Oct-Dec;53(4):207-11. Romanian.

PMID:
16106733
10.

Gastroesophageal reflux disease: new treatments.

Katz PO.

Rev Gastroenterol Disord. 2002;2(2):66-74. Review.

PMID:
12122962
11.

Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.

Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.

Am J Gastroenterol. 1996 Sep;91(9):1766-72.

PMID:
8792695
12.

Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.

Kiljander T, Rantanen T, Kellokumpu I, Kööbi T, Lammi L, Nieminen M, Poussa T, Ranta A, Saarelainen S, Salminen P.

Clin Respir J. 2013 Jul;7(3):281-7. doi: 10.1111/crj.12005. Epub 2012 Oct 24.

PMID:
23006321
13.

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I.

J Am Coll Surg. 2001 Feb;192(2):172-9; discussion 179-81.

PMID:
11220717
14.

[GERD (gastroesophageal reflux disease)].

Dobashi K.

Nihon Rinsho. 2001 Oct;59(10):2045-50. Review. Japanese.

PMID:
11676152
15.

Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.

Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.

Laryngoscope. 2005 Jul;115(7):1230-8.

PMID:
15995512
16.

The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.

Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ.

Am J Gastroenterol. 2010 Nov;105(11):2341-6. doi: 10.1038/ajg.2010.368. Epub 2010 Sep 14.

PMID:
20842110
17.

Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.

Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, Illueca M.

J Pediatr Gastroenterol Nutr. 2007 Nov;45(5):520-9.

PMID:
18030228
18.

Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.

Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M.

J Pediatr Gastroenterol Nutr. 2008 May;46(5):524-33. doi: 10.1097/MPG.0b013e318176b2cb.

PMID:
18493207

Supplemental Content

Support Center